NCT02289040

Brief Summary

Acute kidney injury (AKI) complicates over 50% of cardiac surgical procedures in children where it increases morbidity and the use of healthcare resources. The pathogenesis of AKI is poorly understood, current diagnostic tests lack specificity and sensitivity, and there is no effective treatment. Improving outcomes in patients at risk of AKI has recently been defined as a National Health Service priority. The investigators are currently undertaking a program of work that is evaluating the role of plasma-derived microvesicles (MV) and MV associated microRNAs (miRNA) as diagnostic biomarkers or therapeutic targets in cardiac surgery patients at risk of developing AKI. Preliminary results indicate that these biomarkers may have clinical utility in adults. An important consideration is whether these biomarkers also have utility in children undergoing cardiac surgery. Measurement of MV at serial time points in children presents ethical challenges related to conducting clinical research in critically ill subjects. It also presents technical challenges related to the very small volumes of blood that may be sampled safely from babies and infants undergoing surgery. The aim of the study is to provide estimates of the perioperative variance of MV concentrations in 24 children undergoing cardiac surgery, as well as the frequency of AKI and other adverse events, protocol adherence and recruitment rates. This will assist with the design of a subsequent prospective observational study that will consider the role of MV/miRNA in children undergoing cardiac surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 2, 2014

Completed
29 days until next milestone

Study Start

First participant enrolled

October 1, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 13, 2014

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

January 30, 2020

Status Verified

May 1, 2017

Enrollment Period

2.6 years

First QC Date

September 2, 2014

Last Update Submit

January 29, 2020

Conditions

Keywords

Acute Kidney InjuryMicrovesiclesmicroRNAPaediatric cardiac surgery

Outcome Measures

Primary Outcomes (2)

  • change from baseline in annexin V positive microvesicles

    Mean plasma concentration of Annexin V positive MV and the concentration variance in plasma from arterial blood samples collected prior to anaesthetic induction, and at 6-12 and 24 hours postoperatively.

    Pre-operatively, 6-12 hrs post-op and 24 hrs post-op

  • change from baseline in microvesicles derived miRNA

    Mean plasma concentration of MV derived miRNA and the concentration variance in plasma from arterial blood samples collected prior to anaesthetic induction, and at 6-12 and 24 hours postoperatively.

    Pre-operatively, 6-12 hrs post-op and 24 hrs post-op

Secondary Outcomes (10)

  • Eligibility

    pre-operatively

  • Recruitment

    preoperatively

  • Protocol non-adherence

    Pre-operatively, 6-12 hrs post-op and 24 hrs post-op

  • Acute Kidney Injury

    preoperatively, postoperatively every day until day 7

  • Variation in Renal inflammation

    Pre-operatively, 6-12 hrs post-op and 24 hrs post-op

  • +5 more secondary outcomes

Study Arms (1)

Children undergoing cardiac surgery

Paediatric patients (\<17 years with a body weight \>2000g) undergoing cardiac surgery for congenital heart disease with extracorporeal circulation

Procedure: cardiac surgery

Interventions

cardiac surgery with extracorporeal circulation for congenital heart disease

Children undergoing cardiac surgery

Eligibility Criteria

Age1 Day - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children undergoing cardiac surgery in a tertiary academic cardiac surgery unit

You may qualify if:

  • Patients undergoing congenital heart operations with cardio-pulmonary bypass.
  • Patients aged ≤ 17 years of age.
  • Patients with a body weight \> 2kg.

You may not qualify if:

  • Patients with pre-existing inflammatory state: sepsis undergoing treatment, acute kidney injury within 5 days or chronic inflammatory disease.
  • Emergency (operation before the beginning of the next working day after decision to operate) or salvage procedure (patients requiring cardiopulmonary resuscitation - external cardiac massage - en route to the operating theatre or prior to induction of anaesthesia. This does not include cardiopulmonary resuscitation following induction of anaesthesia)
  • Patients where Extracorporeal Membrane Oxygenation (ECMO) support is required.
  • Patients likely to require ECMO postoperatively.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Glenfield Hospital

Leicester, Leicestershire, LE3 9QP, United Kingdom

Location

Related Publications (1)

  • Sullo N, Mariani S, JnTala M, Kumar T, Wozniak MJ, Smallwood D, Pais P, Westrope C, Lotto A, Murphy GJ. An Observational Cohort Feasibility Study to Identify Microvesicle and Micro-RNA Biomarkers of Acute Kidney Injury Following Pediatric Cardiac Surgery. Pediatr Crit Care Med. 2018 Sep;19(9):816-830. doi: 10.1097/PCC.0000000000001604.

Biospecimen

Retention: SAMPLES WITH DNA

* serum * EDTA plasma * citrated blood * hirudin blood * urine

MeSH Terms

Conditions

Acute Kidney Injury

Interventions

Cardiac Surgical Procedures

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Cardiovascular Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical Procedures

Study Officials

  • Gavin J Murphy, Prof

    University of Leicester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2014

First Posted

November 13, 2014

Study Start

October 1, 2014

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

January 30, 2020

Record last verified: 2017-05

Locations